EMAIL THIS PAGE TO A FRIEND

Biochimica et biophysica acta

From glycosylation disorders back to glycosylation: what have we learned?


PMID 19007883

Abstract

Diseases of glycosylation have long remained confined to the rare hematological disorders, the Tn-syndrome and paroxysmal nocturnal hemoglobinuria. This rarity was often interpreted as a sign that defects of glycosylation are either lethal, or remain asymptomatic because of the large redundancy found in glycosylation pathways. The description of multiple glycosylation disorders over the last years has definitively settled the issue and demonstrated the broad range of biological processes relying on proper glycosylation. However, beyond establishing the developmental and physiological roles of glycosylation how did glycosylation disorders provided new insights to the field of glycobiology?

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

C8271
Cytidine-5′-monophospho-N-acetylneuraminic acid sodium salt, ≥85% (HPLC)
C20H30N4NaO16P